×


CSI Cardiology Update 2020 at Meripustak

CSI Cardiology Update 2020 by PP Mohanan and MN Krishnan, Evangel Publishing

Books from same Author: PP Mohanan and MN Krishnan

Books from same Publisher: Evangel Publishing

Related Category: Author List / Publisher List


  • Price: ₹ 3995.00/- [ 13.00% off ]

    Seller Price: ₹ 3476.00

Sold By: Machwan      Click for Bulk Order

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available

Estimated Delivery Time : 06-Mar-2021


Click for International Orders
  • We deliver across all postal codes in India

  • MeriPustak’s books are 100 % New & Original copy
  • General Information  
    Author(s)PP Mohanan and MN Krishnan
    PublisherEvangel Publishing
    Edition2021 Edition
    ISBN9788194466796
    Pages1048
    BindingHardbound
    LanguageEnglish
    Publish YearDecember 2020

    Description

    Evangel Publishing CSI Cardiology Update 2020 by PP Mohanan and MN Krishnan

    Contents
    Section 1 The Indian Scenario
    1. Clinical Cardiology: The Journey So Far and a Peep into the Future........................................ 3
    RP Sapru
    2. Global, Regional, and National Epidemiology of Hypertension: A Brief Overview................. 13
    Rajeev Gupta, Kiran Gaur
    3. Diabetes: A Major Risk Factor for Ischemic Heart Disease in India......................................26
    KR Thankappan, GK Mini
    4. Challenges in Management of STEMI in India........................................................................ 31
    Snehal Jayaram, Sabari Rajan, Thomas Alexander
    5. Disease Burden and Epidemiology of Heart Failure in India..................................................36
    Shaheer Ahmed, Ambuj Roy
    6. Prevention and Control of Rheumatic Fever in India.............................................................. 47
    Sayed Abdul Khadar
    Section 2 Preventive Cardiology
    7. Lipoprotein(a) as Ischemic Heart Disease Risk Factor: Lessons from Epidemiology, Genetics, and Drug Trials..........................................................55
    SS Iyengar
    8. Cardiovascular Disease Polypills..............................................................................................62
    Mark D Huffman
    9. Triglycerides and Cardiovascular Risk: Have we Reached a Consensus?..............................74
    Vyom Mori, Simran Sawhney, JPS Sawhney
    10. PCSK9 Inhibitors: Current Status.............................................................................................78
    Harinder K Bali, Amreen Dhindsa
    11. Raise the High-density Lipoprotein: Is it Worth the While?....................................................90
    Saumitra Ray, Biswarup Sarkar
    12. Primary Prevention of Cardiovascular Events: Current Role of Aspirin..................................95
    Karunadas
    13. Genetic Testing: Is it Useful Cardiovascular Disease Risk Assessment?............................100
    Rajendra Kumar Jain, Surya Kanth Zena
    Section 3 Controversies in Cardiology
    14. Renal Denervation Therapy for Hypertension: Where does it Stand (or Sit) at Present?...............................................................................105
    C Venkata S Ram
    15. Revascularization in Stable Ischemic Heart Disease: Have the Courage to Leave Alone..........................................................................................113
    Ashwin B Mehta, Nihar Mehta
    16. Controversies in Diet and Cardiovascular Health: An Unending Debate...............................................................................................................121
    Rajan Joseph Manjuran
    17. Controversies in ST-segment Elevation Myocardial Infarction-Percutaneous Coronary Intervention....................................................................127
    CG Bahuleyan
    18. Invasive Management of NSTEMI: Early or Elective?............................................................133
    A George Koshy, Jostol Pinto
    19. Coronary Artery Bypass Grafting versus Percutaneous Coronary Intervention for Left Main Stenosis: Has the Debate Settled?............................................ 141
    Ajit G Desai, Nikesh D Jain
    20. Antiplatelet Therapy after Percutaneous Coronary Intervention: Duration, Combinations, and Switching................................................................................150
    Sajeev CG, Sajeer Kalathingathodika
    Section 4 Hypertension
    21. Hypertension: New Definitions and Goals.............................................................................155
    Shishu Shankar Mishra, Biswaranjan Mishra, Satyanarayan Routray, Akshaya Kumar Samal
    22. Ambulatory Blood Pressure Monitoring and Home Blood Pressure Monitoring: The Way Forward.......................................................................159
    KV Sahasranam
    23. Nonpharmacological Management of Hypertension: Is it Effective?...................................163
    Prabhash Chand Manoria, Pankaj Manoria, Sourabh Dudve
    24. Rational Choice of Antihypertensive Treatment: Current Update........................................167
    Mrinal Kanti Das, Late Tapan Sinha
    25. Management of Hypertensive Emergencies.........................................................................175
    Praveen Jain, Tanul Jain, Mohammad Jibran
    Section 5 Imaging and Physiology in Cardiology
    26. Strain Mimics and Longitudinal Strain Images: Need for Detailed 2D Echo Analysis for Understanding the Meaning of Strain Images...................................183
    G Vijayaraghavan, S Sivasankaran
    27. 3D Echocardiography in Mitral Valve Disease: An Indispensable Tool?..............................187
    V Amuthan, RVA Ananth, AB Gopalamurugan
    28. Advances in Tissue Doppler Echocardiography.....................................................................211
    Jagdish C Mohan, Madhu Shukla
    29. Diastolic Stress Test................................................................................................................222
    VK Katyal, Sandeep Goyal, Komal Dahiya
    30. Cardiologist’s Golden Tip from Lung Sonography “One Minute Echo Pulmogram”.............................................................................................227
    Johny Joseph, Deepak Davidson, Thomas George, Joby K Thomas
    31. Optical Coherence Tomography: A Unique Vascular Imaging Tool.......................................233
    Rony Mathew, Vijin Joseph, Jimmy George
    32. Atheroma Imaging...................................................................................................................245
    Lekha Adik Pathak, Ronak V Ruparelia
    33. Coronary Physiology Evaluation Update.................................................................................249
    Paul V George, John Jose
    34. Coronary Computed Tomographic Angiography in Chronic Coronary Syndromes.................................................................................................256
    Govindan Unni T
    Section 6 Coronary Artery Disease
    35. Does Coronary Artery Disease have an Infectious Etiology?................................................263
    I Sathyamurthy, KN Srinivasan
    36. The Natural Course of Nonculprit Coronary Artery Lesions in
    ST-elevation Myocardial Infarction.........................................................................................270
    Dhiman Kahali, Aniruddha Mandal, Ranita Saha, Asit Das
    37. Vulnerable Plaque, Vulnerable Myocardium,
    Vulnerable Blood and Vulnerable Patient..............................................................................282
    Seemala Saikrishna Reddy, V Pavan Teja, Sivasubramanian Ramakrishnan
    38. Coronary Artery Disease in Women: What is New in 2020?................................................287
    Krishnan Suresh, Harihara Subramonia Sharma TS
    39. Angina with Normal Coronaries: Mechanism, Prognosis, and Management..................................................................................................291
    Satyendra Tewari, Ritesh Kumar Pandey
    40. Subclinical Atherosclerosis to Plaque
    Progression and Acute Events................................................................................................296
    VS Narain, Akshyaya Pradhan, Pravesh Vishwakarma
    41. Ischemic Conditioning: Myth or Realty?.................................................................................301
    Pradeep Kumar Hasija, Anup Banerji
    42. Natriuretic Peptides in Acute Coronary Syndromes..............................................................308
    Nakul Sinha
    43. Screening for Asymptomatic Coronary Artery Disease: Current Status...............................312
    Anil Dhall, Puneet Gupta
    44. Anti-inflammatory Treatment in Coronary Artery Disease: A Review...................................328
    K Sarat Chandra, Kunal Mahajan
    45. Management of Coronary Artery Disease in Chronic Kidney Disease.................................336
    Parneesh Arora, Vineet Bhatia, Upendra Kaul
    46. Late Presentation of ST-elevation Myocardial Infarction: The Missed Opportunity?........................................................................................................344
    Meeraji Rao, Abhisekh Mohanty
    47. Pharmacoinvasive Strategy for Acute ST-segment Elevation Myocardial Infarction: The Way to Go?...................................................................................348
    Sunitha Viswanathan
    48. Thrombolysis in ST-elevation Myocardial Infarction during COVID Pandemic: Regaining a Lost Art..................................................................................355
    HK Chopra, Viveka Kumar, AK Pancholia
    49. Management of Refractory Angina in a “No Option Coronary Artery Disease”....................................................................................361
    Roopa Salwan, Mohit M Bhagwati
    50. Cardiogenic Shock: Current Trends in Classification and Management.............................369
    Surender Deora, Kewal C Goswami
    51. Dual Antiplatelet Therapy Usage beyond One Year: Trials versus Real World Practice........................................................................................... 376
    A Sreenivas Kumar, Ramakrishna Janapati
    Section 7 Valvular Heart Disease
    52. Assessment of Severity of Regurgitant Lesions: Pitfalls and Limitations in Echocardiography........................................................................383
    Harsha Basappa, Satish C Govind
    53. Role of Computed Tomography Angiography and Cardiac Magnetic Resonance Imaging in Valvular Heart Disease.......................................388
    Johann Christopher
    54. Pathophysiology and Management of Severe Aortic Stenosis.............................................399
    Sai Satish
    55. Prevention and Management of Prosthetic Valve Complications........................................412
    Ashokan Nambiar, Rajesh Muralidharan
    56. Evaluation and Management of Secondary Mitral Regurgitation........................................421
    Manish Bansal, Ravi R Kasliwal
    57. Evolution of Transcatheter Aortic Valve Replacement in India: An Update...........................................................................................430
    Sanjay Mehrotra
    Section 8 Peripheral Vascular Disease
    58. Interventional Management of Chronic Occlusive Peripheral Artery Disease: Techniques, Gadgets, and Outcomes........................................439
    BC Srinivas, Vijaykumar JR, Nagesh CM, Babureddy
    59. Management of Infragenicular (Infrapopliteal) Peripheral Arterial Disease.....................................................................................................449
    Asishkumar Mandalay, SR Nair
    60. Management and Prevention of Deep Vein Thrombosis......................................................463
    KH Srinivasa, Vijaykumar JR, CN Manjunath
    61. Renal Artery Stenosis: To Stent or not?.................................................................................470
    Yash Paul Sharma, Anita Sharma, Prashant Kumar Panda, Lipi Uppal, Pruthvi CR
    62. Vascular Compression Syndromes......................................................................................... 474
    Prabha Nini Gupta
    Section 9 Interventional Cardiology
    63. Percutaneous Coronary Intervention in High-bleeding Risk Candidates..............................................................................................485
    Shirish (MS) Hiremath, Satishkumar S Kolekar
    64. Coronary Artery Disease and Atrial Fibrillation—A DEADLY DYAD: Special Focus on Percutaneous Coronary Intervention in Atrial
    Fibrillation Patients on Anticoagulation.................................................................................490
    Manoranjan Mandal, Debajyoti Datta, Souvik Ray
    65. Drug-eluting Balloons in Coronary Artery Disease: Hope or Hype?.....................................494
    Sunil Roy TN, Anil Kumar R
    66. Slow Flow and No-reflow in Coronary Intervention: How to Prevent and Treat it?..................................................................................................502
    Jabir Abdullakutty, Musna PJ, Jimmy George
    67. Coronary Perforation: The Nightmare of an Interventionist................................................. 510
    Deepak Davidson, Johny Joseph, Thomas George, Joby K Thomas
    68. Role of Glycoprotein IIb-IIIa Inhibitors in 2020......................................................................518
    G Justin Paul, PM Nageshwaran, Suriyakanth S
    69. Laser Angioplasty....................................................................................................................522
    CN Manjunath, L Sridhar
    70. Vascular Access Closure Devices: An Overview.....................................................................529
    Saurabh Mehrotra, Navjyot Kaur, Sundeep Mishra
    71. Percutaneous Coronary Intervention in Women: Is Gender Still an Issue?.........................537
    Dharmendra Jain, Umesh Kumar Pandey, Abhishek Kaushley
    72. Patent Foramen Ovale Closure: When and how?..................................................................541
    Nishanth KR, KS Ravindranath
    73. Transcatheter Pulmonary Valve Implantation.......................................................................547
    John Jose, Sudhakar P
    74. Transcatheter Mitral Valve Replacement...............................................................................555
    Rajiv C
    Section 10 Heart Failure
    75. Heart Failure with Preserved Ejection Fraction: Current Trends in Diagnosis and Management.............................................................................................. 571
    Ajay Bahl, Inder Anand
    76. Heart Failure: New Biomarkers..............................................................................................578
    Sandeep Seth
    77. Monitoring in Chronic Heart Failure.......................................................................................582
    BP Singh, Ravi Vishnu Prasad, Nirav Kumar, Gautam Kumar
    78. Anemia, Iron Deficiency and Heart Failure............................................................................589
    VK Chopra, SD Anker
    79. Newer Medical Therapies for Treatment of Heart Failure with Reduced Ejection Fraction.................................................................................593
    Mohan V Deshpande, Avinash Arke, NV Deshpande
    80. Angiotensin Receptor Neprilysin Inhibitor: Current Status and Expanding Indications............................................................................607
    Ankita Kulkarni, Prafulla Kerkar
    81. Revascularization in Ischemic Heart Failure.........................................................................612
    Satyavan Sharma
    82. Left Ventricular Assist Devices in Heart Failure: Bridge or Destination?.............................616
    Bagirath Raghuraman
    83. Heart Failure with Recovered Ejection Fraction: Implications for Prognosis and Management........................................................................623
    Harikrishnan S
    84. Drug-induced Heart Failure: Mechanism, Prevention, Monitoring, and Management............................................................................629
    Arup Dasbiswas, Swati Lad, Ashwini Patil
    85. Vaccination in Heart Failure...................................................................................................634
    Vidyut Jain, Avani Jain
    86. Selection and Evaluation of Patients for Cardiac Transplantation.......................................638
    Talha Meeran
    Section 11 Cardiac Electrophysiology and Arrhythmias
    87. Disorders of Myocardial Repolarization: Molecular Mechanisms and Electrical Manifestations..........................................................................645
    Jaganmohan A Tharakan
    88. Noninvasive Maneuvers and Phenomena to Unravel Tachycardia Mechanism............................................................................................663
    Avishek Bagchi, Yash Lokhandwala
    89. Evaluation and Management of Brugada ECG Pattern........................................................ 674
    Arun Gopi
    90. Congenital Long-QT Syndrome: Diagnosis and Management..............................................679
    Nishad Chitnis, B Hygriv Rao
    91. Novel Mechanisms in Pathogenesis of Atrial Fibrillation......................................................685
    Johnson Francis
    92. Atrial Fibrillation and Heart Failure........................................................................................689
    Gautam Singal, Vikas Kataria, Amitabh Yaduvanshi, Pritam Kitey, Mohan Nair
    93. Atrial Fibrillation and Cognitive Function...............................................................................696
    Anindya Ghosh, Aditya Kapoor
    94. Non-Vitamin K Antagonist Oral Anticoagulants in Valvular Atrial Fibrillation: A Critical Appraisal.....................................................................................701
    Chandrabhan Meena, Harnish Bhatia, Shekhar Kunal
    95. Stroke Prevention in Atrial Fibrillation: Nonpharmacological Modalities.............................709
    Abraham Oomman
    96. Conduction System Pacing: A Comprehensive Review......................................................... 712
    Shunmuga Sundaram Ponnusamy, Narayanan Namboodiri
    97. Leadless Devices for Arrhythmia Management.....................................................................720
    Ajit Thachil
    98. Implantable Cardioverter Defibrillator for Primary Prophylaxis: The Guidelines and Beyond...............................................................................727
    KU Natarajan, Nischal N Hegde
    99. Ventricular Tachycardia Storm: How to Manage?..................................................................735
    Mukund Prabhu, Ajit Kumar VK
    100. Management of Ventricular Arrhythmias in Nonischemic Cardiomyopathy: Beyond Pharmacotherapy.......................................................................... 742
    Vickram Vignesh Rangaswamy, Daljeet Kaur Saggu, Calambur Narasimhan
    101. Tachycardiomyopathy: An Update........................................................................................... 749
    Rabindra Nath Chakraborty, Arindam Pande
    102. Wearable Monitoring Devices in Heart Failure: Indian Perspective.....................................757
    Kalyan Dutta
    103. Magnetic Resonance Imaging in Cardiac Electrophysiology................................................ 761
    Kamal K Sethi, Kabir Sethi
    Section 12 Aortic Disease
    104. Aortic Dissection: Pathophysiology and Evaluation.............................................................. 771
    Rajesh G
    105. Recent Advances in Endovascular Aortic Aneurysm Repair.................................................777
    George Joseph
    106. Hybrid Repair of Aortic Aneurysms.........................................................................................795
    NN Khanna, Markendey Khanna, Francis Asogwa
    Section 13 Myocardial Diseases
    107. Role of Cardiac Magnetic Resonance Imaging in Myocardial Diseases..............................805
    Mona Bhatia, Parveen Kumar
    108. Risk Stratification and Management of Hypertrophic Cardiomyopathy..............................813
    Arnab Banerjee, Debabrata Roy
    109. Amyloid Cardiomyopathy.........................................................................................................819
    Aayush K Singal, Aseem Basha, Nitish Naik
    Section 14 Cardiac Surgery
    110. Acute Aortic Dissection Current Management Strategies....................................................829
    Bashi V Velayudhan, A Mohammed Idhrees
    111. Total Arterial Revascularization: Current Perspectives.........................................................839
    Shiv Kumar Nair, George Jose Valooran, Rinett Sebastian
    112. Off-pump Coronary Artery Bypass: The Game Changer........................................................844
    Murali P Vettath
    113. Chronic Thromboembolic Pulmonary Hypertension: Current Status of Diagnosis and Management.....................................................................850
    Julius Punnen, Varun Shetty, Devi Shetty
    114. Reconstructive Mitral Valve Surgery......................................................................................855
    Praveen Kerala Varma
    115. Heart Transplantation in India: The Past, Present, and Future............................................859
    Jo Joseph, Jose Chacko Periappuram
    Section 15 Miscellaneous
    116. Advanced Interventional Therapy in Pulmonary Arterial Hypertension...............................867
    Manotosh Panja, Madhumanti Panja
    117. Sodium-glucose Cotransporter 2 Inhibitors and Cardiovascular System............................877
    N Sudhayakumar
    118. Cardiac Rehabilitation: Our Approach....................................................................................884
    Ambalam M Chandrasekaran, Dorairaj Prabhakaran
    119. Frailty and Cardiovascular Disease........................................................................................894
    K Venugopal
    120. Non-Vitamin K Antagonist Oral Anticoagulants: An Update (Selecting an NOAC in Atrial Fibrillation)................................................................................898
    Suraj Arora, Bhupinder Singh, Gurpreet S Wander
    121. Contrast Nephropathy: Current Insights on Prevention and Management.................................................................................................906
    Jayagopal PB, Jain T Kallarakkal
    122. Takotsubo Syndrome: Recent Status.....................................................................................911
    Amal Kumar Banerjee
    123. Pulmonary Embolism: New Insights for Risk Stratification and Management............................................................................................. 917
    Anjan Lal Dutta, Soumik Chaudhuri
    124. Cardioprotection in Contemporary Oncology Practice..........................................................931
    Late Tapan Sinha, Mrinal Kanti Das
    125. Intestinal Microbiota in Cardiovascular Health and Disease...............................................936
    Harsh Wardhan, Pranay Gore, Barun Kumar
    126. Postural Orthostatic Tachycardia Syndrome..........................................................................941
    Vijay Garg, Ajay Patidar, Yashveer Rajawat
    127. Cryptogenic Stroke and Patent Foramen Ovale....................................................................945
    RK Saran, Mahim Saran, Vasudha Jain
    128. Erectile Dysfunction: Risk Predictor for Cardiovascular Events...........................................948
    Ashok Goyal
    129. Hyperkalemia: Updates on Outcomes and Therapeutic Strategies.....................................959
    Vitull K Gupta, Meghna Gupta, Varun Gupta
    130. Statins and Cognitive Function...............................................................................................962
    Raviteja Rao Babburi, Dayasagar Rao Vala
    131. Obstructive Sleep Apnea and Cardiovascular Disease.........................................................970
    Smit Shrivastava
    132. Anticoagulation in Pregnancy: A Blessing in Disguise.......................................................... 974
    Snigdha Boddu, Sharad Chandra
    133. Infective Endocarditis Prophylaxis: Current Status...............................................................979
    SB Gupta
    134. Risk Factors for Heart Disease: Do not Underestimate Stress............................................982
    S Shanmugasundaram
    Index....................................................................................................................................... 991